Aicuris Anti-infective Cures AG is a German biopharmaceutical company engaged in the development of antiviral and antibacterial compounds to address severe, often unmet infectious diseases. Founded as a spin-off from Bayer Healthcare, the company focuses on innovative therapies, particularly in the areas of human cytomegalovirus (CMV) and herpes simplex virus (HSV) infections.
